Further research is needed to better assess the prevalence of CD94+ CLLs and possibly other lymphoid neoplasms and determine their clinical significance, potentially opening up new therapeutic possibilities tailored to the individual canine patient. The gene discussed is KLRD1; the disease is lymphoid neoplasm.